Hepatitis C News

What drew me to infectious diseases was the potentially enormous impact it has — not only on individuals but on societies.

Patients with injection drug use-associated infections were less likely to be readmitted to the hospital or die when they were treated by a clinical team that integrated infectious disease and substance use disorder care, researchers found.

Testing for HIV, hepatitis B, and hepatitis C increased among U.S. Medicaid enrollees initiating treatment for opioid use disorder. However, a recent study showed approximately three-quarters of enrollees were not tested for each condition.

WASHINGTON — Active IV or prescription drug use did not affect attainment of sustained virologic response when treatment adherence for hepatitis C virus was already variable, according to a poster presented at The Liver Meeting.

Direct-acting antiviral treatment significantly lowered the risk for mortality and liver and non-liver outcomes in patients with chronic hepatitis C virus infection, regardless of disease stage, researchers reported.

In 2022, the front page of Infectious Disease News mostly peered beyond COVID-19 to showcase triumphs and progress being made elsewhere in the field of infectious disease.

There was plenty of FDA news this year not related to COVID-19.

We continue to be captivated by the stories you tell in our “Hooked on ID” series.

I got into the medical field to solve problems, and the field of infectious diseases exemplifies that.

At the end of this month, Anthony S. Fauci, MD, will officially step down as director of the National Institute of Allergy and Infectious Diseases, which he has led for nearly 4 decades.